MedTrace Logo

Myocardial Infarction Size Reduction With Atorvastatin

NCT00286312 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-05-21

No results posted yet for this study

Summary

The purpose of this study is to determine if oral atorvastatin administered just before percutaneous coronary angioplasty for acute myocardial infarction improves early and late heart function as compared to placebo.

Conditions

Interventions

DRUG

Atorvastatin

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • R&D Cardiologie

    lead OTHER

Principal Investigators

  • Benno Rensing, MD, PhD · St. Antonius Ziekenhuis Nieuwegein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00286312 on ClinicalTrials.gov